Loading...
Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours
BACKGROUND: Ewing sarcoma/PNET is managed with treatment paradigms involving combinations of chemotherapy, surgery, and sometimes radiation. Although the 5-year survival rate of non-metastatic disease approaches 70%, those cases that are metastatic and those that recur have 5-year survival rates of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3351706/ https://ncbi.nlm.nih.gov/pubmed/22587874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-3329-2-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|